Statistics for Dare Bioscience (id:5665 DARE)

Valuation metrics

Market cap

37.69M

Enterprise value

27.02M

Trailing P/E (ttm)

0.14

Forward P/E

-3.24

PEG ratio

-3.24

Price/Sales (ttm)

13.27

Price/Book (mrq)

14.09

Enterprise Value/Revenue

9.52

Enterprise Value/EBITDA

-1.01

Overview

Shares outstanding

8.55M

Float

8.41M

Shares short

44.50K

% Held by insiders

0.02%

% Held by institutions

0.07%

Average volume (10 days)

42.19K

Average volume (90 days)

Price summary

52-Week low

3.05

52-Week high

7.56

52-Week change

-26.47%

Beta

1.34

50-Day moving average

3.54

200-Day moving average

4.30

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

July 20th, 2017

Ex-dividend date

Last split factor

2:1

Last split date

July 01th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-253.60%

Operating margin

-32,799.12%

Operational effectiveness

Return on assets

-71.42%

Return on equity

597.53%

Income statement

Revenue (ttm)

0.36

Revenue per share (ttm)

0.36

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-26,704,360.00

Net income to common (ttm)

-7,201,358.00

Diluted EPS (ttm)

32.28

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

16.41M

Total cash per share (mrq)

1.92

Total debt (mrq)

5.83M

Total Debt/Equity (mrq)

218.34

Current ratio (mrq)

142.80%

Book value per share (mrq)

0.31

Cash flow

Cash flow statement

-10,061,013.00

Levered free cash flow (LFCF)

-20,976,328.00